Hepatic Targeting of Transplanted Liver Sinusoidal Endothelial Cells in Intact Mice *
Open Access
- 25 May 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 42 (1) , 140-148
- https://doi.org/10.1002/hep.20746
Abstract
Targeting of cells to specific tissues is critical for cell therapy. To study endothelial cell targeting, we isolated mouse liver sinusoidal endothelial cells (LSEC) and examined cell biodistributions in animals. To identify transplanted LSEC in tissues, we labeled cells metabolically with DiI-conjugated acetylated low density lipoprotein particles (DiI-Ac-LDL) or 111Indium-oxine, used LSEC from Rosa26 donors expressing β-galactosidase or Tie-2-GFP donors with green fluorescent protein (GFP) expression, and tranduced LSEC with a GFP-lentiviral vector. LSEC efficiently incorporated 111Indium and DiI-Ac-LDL and expressed GFP introduced by the lentiviral vector. Use of radiolabeled LSEC showed differences in cell biodistributions in relation to the cell transplantation route. After intraportal injection, LSEC were largely in the liver (60 ± 13%) and, after systemic intravenous injection, in lungs (67 ± 9%); however, after intrasplenic injection, only some LSEC remained in the spleen (29 ± 10%; P < .01), whereas most LSEC migrated to the liver or lungs. Transplanted LSEC were found in the liver, lungs, and spleen shortly after transplantation, whereas longer-term cell survival was observed only in the liver. Transplanted LSEC were distinct from Kupffer cells with expression of Tie-2 promoter-driven GFP and of CD31, without F4/80 reactivity. In further studies using radiolabeled LSEC, we established that the manipulation of receptor-mediated cell adhesion in liver sinusoids or the manipulation of blood flow–dependent cell exit from sinusoids improved intrahepatic retention of LSEC to 89 ± 7% and 89 ± 5%, respectively ( P < .01). In conclusion , the targeting of LSEC to the liver and other organs is directed by vascular bed–specific mechanisms, including blood flow–related processes, and cell-specific factors. These findings may facilitate analysis of LSEC for cell and gene therapy applications. (Hepatology 2005.)Keywords
This publication has 44 references indexed in Scilit:
- Emerging insights into liver-directed cell therapy for genetic and acquired disordersTransplant Immunology, 2004
- Targeted gene delivery to sinusoidal endothelial cells: DNA nanoassociate bearing hyaluronan‐glycocalyxThe FASEB Journal, 2004
- Endothelial Cell Development, Vasculogenesis, Angiogenesis, and Tumor Neovascularization: An UpdateSeminars in Thrombosis and Hemostasis, 2004
- Converging roads: evidence for an adult hemangioblastExperimental Hematology, 2003
- Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantationLeukemia, 2003
- RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- Transcytosis of plasma macromolecules in endothelial cells: A cell biological surveyMicroscopy Research and Technique, 2002
- Efficient Gene Delivery and Targeted Expression to HepatocytesIn Vivoby Improved Lentiviral VectorsHuman Gene Therapy, 2002
- 111Indium labeling of hepatocytes for analysis of short-term biodistribution of transplanted cellsHepatology, 1994
- Identification of a fibronectin receptor specific for rat liver endothelial cellsExperimental Cell Research, 1987